A052101
OPEN TO ACCRUAL
Ph 3 Study of Continuous v Intermittent Zanubrutinib Maintenance Therapy in Older Patients with MCL
EA4231
OPEN TO ACCRUAL
P2 Study Testing the Effectiveness of a Combo Targeted Therapy ViPOR for Patients With BCL
EA4232
OPEN TO ACCRUAL
R Ph3 study to Eval Benefits of ASCT in pts w PTCL that achieved a CR1 Following Induction Therapy
S2114
OPEN TO ACCRUAL
Ph II Trial of Consolidation Tx Following CD19 CAR T Tx for Relapse, Refractory DLBCL or Gr IIIB FL
UW19086
OPEN TO ACCRUAL
LTFU Protocol for Subjects Treated with Gene-Modified T Cells
UW20062
OPEN TO ACCRUAL
Metabolic Profiling of Leukemic Cells through Isotope Tracing in Patients with CLL
UW24107
OPEN TO ACCRUAL
Ph3 Study of Soquelitinib vs. Physician's Choice in Pts with R,R PTCL-NOS, FHTCL or sALCL